Share on StockTwits

AMAG Pharmaceuticals (NASDAQ:AMAG) will be posting its quarterly earnings results on Tuesday, July 29th. Individual that wish to register for the company’s earnings conference call can do so using this link.

AMAG Pharmaceuticals (NASDAQ:AMAG) traded down 2.33% on Monday, hitting $18.01. 41,522 shares of the company’s stock traded hands. AMAG Pharmaceuticals has a 52 week low of $16.49 and a 52 week high of $28.42. The stock’s 50-day moving average is $19.39 and its 200-day moving average is $19.68. The company’s market cap is $394.7 million.

On the ratings front, analysts at Zacks downgraded shares of AMAG Pharmaceuticals from a “neutral” rating to an “underperform” rating in a research note on Tuesday, June 24th. They now have a $19.40 price target on the stock. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the company’s stock. AMAG Pharmaceuticals presently has an average rating of “Hold” and a consensus target price of $23.88.

AMAG Pharmaceuticals, Inc is a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia (NASDAQ:AMAG).

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.